News
Theorem Clinical Research Thought Leaders to Present at Partnerships in Clinical Trials Conference
Numerous thought leaders from Theorem Clinical Research, a leading contract research organization that optimizes trial conduct, will participate in speaking engagements and discussions at the Partnerships in Clinical Trials (PCT) Conference in Boston. These events include:
- “Best Practices in Medical Device Trials,” chaired by D. Lee Spurgin Jr., Ph.D., Theorem senior vice president and general manager, medical device and diagnostic development, 1:30 to 5 p.m., Thursday, April 23.
- “Mobile Medical Applications: Implementing an Institution-Wide Strategy for Improved Clinical Outcomes, Increased ROI and at Lower Costs,” presented by Prithul Bom, Theorem director, medical device and diagnostic development, and Elizabeth Brooks, Ph.D., president of Decision Driver Analytics (a Theorem strategic partner), at 1:30 p.m., Thursday, April 23.
- “Wall Street State of the Industry Forecast for 2015: Taking a Closer Look Into the Sustainability of the Pharma/CRO Outsourcing Model,” presented by John Potthoff, Ph.D., Theorem president and CEO, at 2:45 p.m. Friday, April 24.
“PCT provides an exceptional platform for dialogue,” said Potthoff. “We seldom get the opportunity to have so many thought leaders in one place at the same time and, given the variety of topics, it gives our experts a chance to contribute.”
Theorem will also exhibit at booth 400, where its team will be available for meetings. Learn more about Theorem and its leaders at TheoremClinical.com.
About Theorem Clinical Research
Theorem Clinical Research Inc. is a global provider of comprehensive clinical services with staff throughout the Americas, Europe and Asia-Pacific and a client base comprised of the world’s leading biopharmaceutical and medical device companies. With industry-leading experts, unparalleled therapeutic expertise and innovative, groundbreaking technology, Theorem is focused on analytic-based development, combination trials and personal data applications to simplify complex trials.